Relmada Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC RLMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

53,081

Value ($000)

256

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	256	0.0%	53,081	12/31/2025
2024 Q3	11/12/2024	41	0.0%	12,505	9/30/2024
2024 Q2	8/12/2024	38	0.0%	12,505	6/30/2024
2024 Q1	5/9/2024	58	0.0%	12,505	3/31/2024
2023 Q4	2/6/2024	52	0.0%	12,505	12/31/2023
2023 Q3	11/8/2023	38	0.0%	12,505	9/30/2023
2023 Q2	8/10/2023	31	0.0%	12,505	6/30/2023
2023 Q1	5/12/2023	167	0.0%	73,915	3/31/2023
2022 Q4	2/13/2023	214	0.0%	61,410	12/31/2022
2022 Q3	11/14/2022	2,611	0.0%	70,515	9/30/2022
2022 Q2	8/15/2022	1,377	0.0%	72,506	6/30/2022
2022 Q1	5/13/2022	1,809	0.0%	66,996	3/31/2022
2021 Q4	2/11/2022	1,023	0.0%	45,375	12/31/2021
2021 Q3	11/16/2021	1,082	0.0%	41,257	9/30/2021
2021 Q2	8/16/2021	3,175	0.0%	99,167	6/30/2021
2021 Q1	5/17/2021	3,330	0.0%	94,562	3/31/2021
2020 Q4	2/16/2021	2,977	0.0%	92,828	12/31/2020
2020 Q3	11/13/2020	3,365	0.0%	89,436	9/30/2020
2020 Q2	8/20/2020	4,031	0.0%	90,056	6/30/2020
2020 Q1	5/15/2020	1,820	0.0%	53,328	3/31/2020
2019 Q4	2/7/2020	1,919	0.0%	49,187	12/31/2019